-
Product Insights
Chico River hydropower project
Chico River hydropower project is a Hydro project located in Cordillera Administrative Region, Philippines. The project is owned by Prime Metro Power Holdings Corp; San Lorenzo Ruiz Piat Energy and Water Inc and is developed by Chico JV Co. The project is at the permitting stage. Empower your strategies with our Chico River hydropower project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMX-010 in Atopic Dermatitis (Atopic Eczema)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BMX-010 in Atopic Dermatitis (Atopic Eczema) Drug Details: BMX-010 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trientine Hydrochloride in Systolic Heart Failure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trientine Hydrochloride in Systolic Heart Failure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Trientine Hydrochloride in Systolic Heart Failure Drug Details: trientine hydrochloride is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DS-9606a in Germ Cell Tumors
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DS-9606a in Germ Cell Tumors report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.DS-9606a in Germ Cell TumorsDrug Details:DS-9606a is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMX-001 in Head And Neck Cancer Squamous Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMX-001 in Head And Neck Cancer Squamous Cell Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMX-001 in Head And Neck Cancer Squamous...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rivaroxaban in Stroke
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rivaroxaban in Stroke Drug Details: Rivaroxaban is under development for the treatment of stroke and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MET-2 in Clostridioides difficile Infections (Clostridium difficile Associated Disease)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.MET-2 in Clostridioides difficile Infections (Clostridium difficile Associated Disease) Drug Details:MET-2 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMX-001 in High-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMX-001 in High-Grade Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.BMX-001 in High-Grade GliomaDrug Details: BMX-001 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SGR-1505 in B-Cell Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SGR-1505 in B-Cell Non-Hodgkin Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SGR-1505 in B-Cell Non-Hodgkin LymphomaDrug Details:SDGR-3 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MIL-62 in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MIL-62 in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MIL-62 in Follicular Lymphoma Drug Details: MIL-62 is under development for the...